SWOG S1826, a randomized study of nivolumab(N)-AVD versus brentuximab vedotin(BV)-AVD in advanced stage (AS) classic Hodgkin lymphoma (HL) - Herrera, AF; LeBlanc, ML; Castellino, SM (JCO, 2023)